AlphaFlo

AlphaFlo® is a liquid, acellular, canine amniotic tissue allograft comprised of amnion intended to supplement and protect tissues.

12/29/2025

Dr. Mark Besancon will present a live session on Regenerative Medicine in Veterinary Practice: Clinical Applications of Amniotic Tissue Allografts. This in-person event will explore practical, case-based applications of AlphaFlo® and how clinicians are using it in their everyday workflows.

🗓 January 21, 2026
🕕 6 PM
📍 Comal County VMA at The McKenna Center
801 W. San Antonio Street, New Braunfels, TX 78130

Don’t miss this opportunity to learn directly from AlphaFlo®’s Key Opinion Leader!

12/25/2025

From all of us at AlphaFlo® , we’re wishing you a joyful holiday season and a bright start to the New Year. We're grateful for the veterinary professionals who prioritize canine health every day, and we’re honored to support your work.

As you prepare for the year ahead, explore how AlphaFlo® can complement your practice: https://alphaflocanine.com/

12/23/2025

This senior pup went from dragging his legs to helping work the field again, and his story says it all.

“He could hardly walk... now he goes with me to the barn, helps get the calves in the chute, and is back to doing the things he loves.” – Gail A.

Veterinarians are using AlphaFlo® to support mobility and comfort in older dogs like this one, all with a focus on personalized care. Want to learn how AlphaFlo® is being used in the field? Visit: https://alphaflocanine.com/

12/22/2025

Have questions about regenerative care or how AlphaFlo® fits into your workflow? Dr. Mark Besancon is AlphaFlo®'s Key Opinion Leader, also known as a KOL. That means he actively collaborates with the AlphaFlo® team to educate, guide, and support veterinarians as they explore regenerative solutions.

With years of clinical experience and peer consultations under his belt, Dr. Mark is here to answer your practical questions, directly from the field.

Drop your question for Dr. Mark and explore real-world clinical insight: http://alphaflocanine.com/ask-dr-mark-vet/

12/19/2025

AlphaFlo® is a liquid, cryopreserved, canine amniotic tissue allograft designed to supplement and protect tissues. Its use may be minimally invasive, safe, and offer a morbidity profile comparable to or better than existing modalities while supporting consistent clinical outcomes.

Unlike autologous therapies that require culturing or harvesting, AlphaFlo® is readily available and eliminates preparation delays. It also avoids the variability seen with other modalities.

Because AlphaFlo® is cryopreserved rather than lyophilized, key proteins and bioactive components are better maintained, contributing to product consistency, reproducibility across cases and improved clinical outcomes.

Curious about how AlphaFlo® might support your practice? Learn more: https://alphaflocanine.com/

12/16/2025

At 17, Cody’s mobility returned after setbacks that included seizures and loss of limb use.
His owner shared, “Now he is walking and supporting himself... wagging his tail and excited about treats and dinner.”

Cody’s progress is a testament to thoughtful care, consistency, and veterinary support. Want to see how veterinarians are using AlphaFlo® to support canine athletes and recovery cases? Learn more: https://alphaflocanine.com/

12/15/2025

In this comparative case, 14 dogs underwent TPLO procedures. Seven received AlphaFlo® intra-articularly at closure while the other seven did not.

This observational study explores AlphaFlo®’s integration during orthopedic surgery and the clinical outcomes observed. Learn more: https://alphaflocanine.com/tibial-plateau-leveling-osteotomy-case-study/

12/12/2025

Veterinarians across the country are sharing their clinical experiences using AlphaFlo®. From diagnostics to follow-up care, these insights reflect how AlphaFlo® is being integrated into real-world practices to support tissue health.

Curious about what clinicians are seeing? Explore more perspectives: https://alphaflocanine.com/

12/11/2025

Kleio’s care began with a clear diagnosis and clinical plan, giving her a path back to competition. The client shared, “Kleio is on her way to competing competitively again in North America Diving Dogs.”

Her veterinary team supported her through a PSOAS condition using a thorough and individualized approach. Want to see how veterinarians are using AlphaFlo® to support canine athletes and recovery cases? Learn more: https://alphaflocanine.com/

12/10/2025

In this new blog, Dr. Mark Besancon outlines how his approach evolved from viewing regenerative therapies as a secondary option to making AlphaFlo® a foundational part of care.

He writes, “As outcomes improved and cases responded more quickly and more completely, it became clear that this tool belongs at the front of the treatment plan.”

Read now: https://alphaflocanine.com/alphaflo-veterinarian-clinical-approach-regenerative-therapy/

12/09/2025

AlphaFlo® was proud to connect with veterinary surgeons and clinicians at ACVS in Seattle. From regenerative applications to peer conversations, we’re grateful for the opportunity to share how AlphaFlo® is supporting practices nationwide.

Want more info on integrating AlphaFlo® into your workflow? Learn more: https://alphaflocanine.com/

Address

308 E FM 1830, Building 2 Suite A
Argyle, TX
76226

Telephone

(501)7085000

Website

http://www.Alphaflocanine.com/

Alerts

Be the first to know and let us send you an email when AlphaFlo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.